Long-term outcome in kidney transplant recipients over 70 years in the eurotransplant senior kidney transplant program: A single center experience

Transplantation

Volumn 92, Issue 2, 2011, Pages 210-216

  Boesmueller, Claudia ^a   Biebl, Matthias ^a   Scheidl, Stefan ^a   Oellinger, Robert ^a   Margreiter, Christian ^a   Pratschke, Johann ^a   Margreiter, Raimund ^a   Schneeberger, Stefan ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

ET senior program; Kidney transplant; Long term outcome

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; METHYLPREDNISOLONE;

ACUTE GRAFT REJECTION; AGE; AGED; BONE DISEASE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; COLD ISCHEMIA; COLD ISCHEMIA TIME; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; METABOLIC DISORDER; NEOPLASM; NEUROLOGIC DISEASE; PLASMAPHERESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; URINARY TRACT DISEASE;

AGE FACTORS; AGED; COMORBIDITY; EUROPE; FEMALE; GRAFT SURVIVAL; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; TRANSPLANTATION;

EID: 79960299400     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318222ca2f     Document Type: Review

References (15)

1. Cohen B, Smits JM, Haase B, et al. Expanding the donor pool to in-crease renal transplantation. Nephrol Dial Transplant 2005; 20: 34.
2. De Fijter JW. An old virtue to improve senior programs. Transpl Int 2009; 22:259.
3. Rudge C. Long-term patient and graft survival in the Eurotransplant senior program: A single center experience. Transplantation 2005; 80: 571.
4. Raine A, Margreiter R, Brunner F, et al. Report on management ofrenal failure in Europe, XXII, 1991. Nephrol Dial Transpl 1992; (suppl2):7.
5. Pratschke J, Merk V, Reutzel-Selke A, et al. Potent early immune re-sponse after kidney transplantation in patients of the European senior program. Transplantation 2009; 87: 992.
6. Frei U, Noeldeke J, Machold-Fabrizii V, et al. Prospective age-matching in elderly kidney transplant recipients\-A 5-years analysis of the Eu-rotransplant senior program. Am J Transplant 2008; 8: 50.
7. Stratta R, Sundberg A, Rohr M, et al. Optimal use ofolder donors and recipients in kidney transplantation. Surgery 2006; 139: 324.
8. Pilmore H. Cardiac assessment for renal transplantation. Am J Transpl 2006; 6:659.
9. Fabrizii V, Kovarik J, Bodingbauer M, et al. Long-term patient and graft survival in the Eurotransplant senior program: A single center experi-ence. Transplantation 2005; 80: 582.
10. Emparan C, Wolters H, Laukötter M, et al. Long-term results of Calcineurin-free protocols with Basiliximab induction in "old to old-" programs. Transpl Proc 2004; 36:2646.
11. Bösmüller C, Öllinger R, Mark W, et al. Excellent results with Calcineu-rin inhibitor-free initial immunosuppression in old recipients ofold kidneys. Transpl Proc 2005; 37:881.
12. Segoloni G, Messina M, Squiccimarro G, et al. Preferential allocation of marginal kidney allografts to elderly recipients combined with modi-fied immunosuppression gives good results. Transplantation 2005; 80: 953.
13. Oniscu G, Brown H, Forsythe J. How great is the survival advantage of transplantation over dialysis in elderly patients? Nephrol Dial Transplant 2004; 19: 945.
14. Kaufman S, Shim J, Russ A. Revisiting the biomedicalization ofaging: Clinical trends and ethical challenges. Gerontologist 2004; 44: 731.
15. Zeber J, Copeland L, Hosek B, et al. Cancer rates, medical comorbidi-ties, and treatment modalities in the oldest patients. Crit Rev Oncol Hematol 2008; 67: 237.